Codexis signs agreement to manufacture 50 g siRNA using its ECO Synthesis® Manufacturing Platform

Stock Information for Codexis Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Codexis Inc.

Codexis to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 11
Codexis to Participate in TD Cowen 46th Annual Health Care Conference
Codexis Achieves ISO 9001:2015 Certification
Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics
Codexis Announces Signing of Lease for GMP Manufacturing Facility
Codexis Reports Third Quarter 2025 Financial Results
Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's ECO Synthesis® Manufacturing Platform for Therapeutic siRNA Manufacturing
Codexis to Report Third Quarter 2025 Financial Results on November 6

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.